{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:40:59Z","timestamp":1794350459696,"version":"4.9.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction generale de l'Armement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010095","name":"R\u00e9gion Hauts-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113981","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T11:21:33Z","timestamp":1636543293000},"page":"113981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in\u00a0vitro antimalarial activity"],"prefix":"10.1016","volume":"228","author":[{"given":"A.","family":"Dassonville-Klimpt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tisnerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Azas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marchivie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mulli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Agnamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Totet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dormoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Taudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113981_bib2","unstructured":"WHO-UCN-GMP-2021.01-eng.pdf, (n.d.)."},{"key":"10.1016\/j.ejmech.2021.113981_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMc1403007","article-title":"Dihydroartemisinin\u2013piperaquine failure in Cambodia","volume":"371","author":"Saunders","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113981_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.328.5980.844","article-title":"Malaria's drug miracle in danger","volume":"328","author":"Enserink","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113981_bib5","article-title":"Antimalarial drug discovery: from quinine to the most recent promising clinical drug candidates","author":"Tisnerat","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib6","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/sj.emboj.7601203","article-title":"Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum","volume":"25","author":"Rohrbach","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113981_bib7","article-title":"Monitoring PfMDR1 transport in Plasmodium falciparum, malar","volume":"14","author":"Reiling","year":"2015","journal-title":"J"},{"key":"10.1016\/j.ejmech.2021.113981_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0166-6851(93)90252-S","article-title":"Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand","volume":"57","author":"Wilson","year":"1993","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113981_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ejmech.2021.113981_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4161\/viru.1.4.12012","article-title":"Functional characteristics of the malaria parasite's \u201cchloroquine resistance transporter\u201d: implications for chemotherapy","volume":"1","author":"Summers","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.ejmech.2021.113981_bib11","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/AAC.00675-10","article-title":"4-Aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses","volume":"55","author":"Hocart","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib12","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/AAC.40.8.1846","article-title":"4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum","volume":"40","author":"Ridley","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13543784.2019.1560419","article-title":"AQ-13 - an investigational antimalarial drug","volume":"28","author":"Mengue","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2021.113981_bib14","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in\u00a0vitro and in\u00a0vivo of a new ferrocene\u2212chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12936-021-03749-4","volume":"20","author":"Adoke","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113981_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/cbdd.12914","article-title":"Design, synthesis and in\u00a0vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain","volume":"89","author":"Kondaparla","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113981_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2012.07.037","article-title":"Synthesis and in\u00a0vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2-a]quinoxaline compounds","volume":"55","author":"van Heerden","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib18","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","article-title":"Identification of an antimalarial synthetic trioxolane drug development candidate","volume":"430","author":"Vennerstrom","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113981_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm00001a026","article-title":"Synthesis and activity of some antimalarial bisquinolines","volume":"38","author":"Raynes","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib20","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/molecules25092251","article-title":"Unsymmetrical bisquinolines with high potency against P.\u00a0falciparum malaria","volume":"25","author":"Liebman","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113981_bib21","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/jm060399n","article-title":"A\u00a0Chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum","volume":"49","author":"Burgess","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib22","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1021\/jm1006484","article-title":"Synthesis, structure\u2212activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds","volume":"53","author":"Burgess","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib23","doi-asserted-by":"crossref","first-page":"e01913","DOI":"10.1128\/AAC.01913-16","article-title":"Simplified reversed chloroquines to overcome malaria resistance to quinoline-based drugs","volume":"61","author":"Gunsaru","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","volume":"65","author":"Davis","year":"2005","journal-title":"Piperaquine, Drugs."},{"key":"10.1016\/j.ejmech.2021.113981_bib25","doi-asserted-by":"crossref","DOI":"10.2174\/1573406413666170726123938","article-title":"Synthesis and antimalarial activity of new enantiopure aminoalcoholpyrrolo[ 1,2-a]quinoxalines","author":"Jonet","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib26","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ejmech.2011.03.014","article-title":"New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in\u00a0vitro antimalarial activity \u2013 Part II","volume":"46","author":"Guillon","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib27","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1016\/j.bmc.2008.09.038","article-title":"New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in\u00a0vitro antimalarial activity","volume":"16","author":"Guillon","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2174\/1570180813666160517164758","article-title":"Design, synthesis and antimalarial activity of some new aminoalcoholpyrrolo[1,2-a]quinoxaline derivatives","volume":"13","author":"Guillon","year":"2016","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2021.113981_bib29","doi-asserted-by":"crossref","DOI":"10.1021\/jm0310840","article-title":"Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and Bispyrrolo[1,2-a]thieno[3,2-e]pyrazines","volume":"47","author":"Guillon","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14756366.2016.1268608","article-title":"Design, synthesis and antimalarial activity of novel bisN-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropylamine derivatives","volume":"32","author":"Guillon","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tetasy.2011.01.003","article-title":"First enantioselective synthesis of 4-aminoalcohol quinoline derivatives through a regioselective SN2 epoxide opening mechanism","volume":"22","author":"Jonet","year":"2011","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2021.113981_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cplu.201300074","article-title":"Absolute configuration and antimalarial activity of erythro -mefloquineenantiomers","volume":"78","author":"Dassonville-Klimpt","year":"2013","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ejmech.2021.113981_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-11-65","article-title":"Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action","volume":"11","author":"Mulli\u00e9","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113981_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tetasy.2015.11.003","article-title":"Asymmetric synthesis of new antimalarial aminoquinolines through Sharpless aminohydroxylation","volume":"27","author":"Bentzinger","year":"2016","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2021.113981_bib35","article-title":"4-Aminoalcoholquinoline derivatives, enantioselective synthesis methods and the use thereof","author":"Jonet","year":"2012","journal-title":"WO"},{"key":"10.1016\/j.ejmech.2021.113981_bib36","doi-asserted-by":"crossref","first-page":"131088","DOI":"10.1016\/j.tet.2020.131088","article-title":"Enantiopure substituted pyridines as promising antimalarial drug candidates","volume":"76","author":"Bentzinger","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113981_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/expr.1993.1042","article-title":"Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents","volume":"76","author":"Karle","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113981_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113981_bib39","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","article-title":"Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs","volume":"74","author":"Fitch","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2021.113981_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113981_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0169-4758(96)10003-X","article-title":"The ATP-binding cassette (ABC) gene family of Plasmodium falciparum","volume":"12","author":"Rubio","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ejmech.2021.113981_bib42","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113981_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/acschembio.9b00003","article-title":"Characterization of Lipid Binding Properties of Plasmodium falciparum acyl-coenzyme A binding proteins and their competitive inhibition by mefloquine","volume":"14","author":"Kumar","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113981_bib44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.2042-7158.1997.tb06047.x","article-title":"Stereoselective passage of mefloquine through the blood-brain barrier in the rat","volume":"49","author":"Baudry","year":"1997","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113981_bib45","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.bjp.0705721","article-title":"Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice","volume":"141","author":"de Lagerie","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113981_bib46","article-title":"Use of (+)-mefloquine for the treatment of malaria","author":"Fletcher","year":"1998","journal-title":"WO 1998039003 A1"},{"key":"10.1016\/j.ejmech.2021.113981_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002280050100","article-title":"Stereoselective pharmacokinetics of mefloquine in young children","volume":"50","author":"Bourahla","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113981_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bmcl.2010.01.001","article-title":"Structure\u2013activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum","volume":"20","author":"Milner","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113981_bib49","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1021\/jm200647u","article-title":"Structure\u2013activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum","volume":"54","author":"Milner","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib50","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1039\/b911483a","article-title":"Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine","volume":"7","author":"Wipf","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-407","article-title":"Enantiomerically pure amino-alcohol quinolines: in\u00a0vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in\u00a0vivo efficacy in a Plasmodium berghei mouse model","volume":"13","author":"Mulli\u00e9","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113981_bib52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/ci0200265","article-title":"A\u00a03D QSAR Pharmacophore model and quantum chemical structure\u2212activity analysis of chloroquine(CQ)-resistance reversal","volume":"42","author":"Bhattacharjee","year":"2002","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2021.113981_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drup.2006.09.002","article-title":"Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum","volume":"9","author":"van Schalkwyk","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2021.113981_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2116\/xraystruct.34.15","article-title":"Crystal structure of 2,8-bis(trifluoromethyl)-4-vinylquinoline","volume":"34","author":"Guillon","year":"2018","journal-title":"X-Ray Struct. Anal. Online."},{"key":"10.1016\/j.ejmech.2021.113981_bib55","unstructured":"Full Crystallographic Results Have Been Deposited at the Cambridge Crystallographic Data Centre (CCDC-1908109), UK, as s, (n.d.)."},{"key":"10.1016\/j.ejmech.2021.113981_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1475-2875-12-239","article-title":"Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex\u00a0vivo field isolates from Cambodia","volume":"12","author":"Chaorattanakawee","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113981_bib57","first-page":"505","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells, Xenobiotica Fate Foreign Compd","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Biol. Syst."},{"key":"10.1016\/j.ejmech.2021.113981_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in\u00a0vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2021.113981_bib59","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/humrep\/deg290","article-title":"A\u00a0culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells","volume":"18","author":"Hovatta","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejmech.2021.113981_bib60","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/infdis\/jir033","article-title":"Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum","volume":"203","author":"Douglas","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113981_bib61","article-title":"Next Generation quinolone methanols related applications","volume":"16","author":"Dow","year":"2010","journal-title":"WO"},{"key":"10.1016\/j.ejmech.2021.113981_bib62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in\u00a0vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib63","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/AAC.01313-06","article-title":"Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in\u00a0vitro antimalarial drug efficacy testing and application to clinical isolates","volume":"51","author":"Bacon","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib64","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.00367-06","volume":"50","author":"Kaddouri","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib65","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","article-title":"Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113981_bib66","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum Erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ejmech.2021.113981_bib67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4269\/ajtmh.2006.74.953","article-title":"Genetic diversity and structure of african Plasmodium falciparum populations in urban and rural areas","volume":"74","author":"Kamil","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113981_bib68","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.2006.75.146","article-title":"Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates","volume":"75","author":"Henry","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113981_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2021.113981_bib70","first-page":"278","article-title":"Protective role of platelets in chronic (Balb\/C) and acute (CBA\/J) Plasmodium berghei murine malaria","volume":"27","author":"Polack","year":"1997","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejmech.2021.113981_bib71","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in\u00a0vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.ejmech.2021.113981_bib72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:35:22Z","timestamp":1759329322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":71,"alternative-id":["S0223523421008308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113981","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in\u00a0vitro antimalarial activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113981"}}